US2007037889A1PendingUtilityA1

Anticancer composition comprising obovatol or obovatal

59
Assignee: KOREA RES INST OF BIOSCIENCEPriority: Aug 11, 2005Filed: Aug 7, 2006Published: Feb 15, 2007
Est. expiryAug 11, 2025(expired)· nominal 20-yr term from priority
Inventors:Byoung-Mog KwonKwang-Hee SonDong HanSu-Kyung LeeJung Min KimYoung-Hee KhoHyo-Kon ChunJae Young Yang
A61K 31/075A61P 35/00A61P 35/04A61K 31/11A61K 31/085A61K 31/05A61K 36/57
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.

Claims

exact text as granted — not AI-modified
1 . An anticancer composition, comprising obovatol, represented by Chemical Formula 1, obovatal, represented by Chemical Formula 2, and/or pharmaceutical salts thereof.  
       
         
           
           
               
               
           
         
       
     
     
         2 . The anticancer composition as set forth in  claim 1 , wherein the anticancer composition is effective to treat cancer selected from among large intestine cancer, rectal cancer, stomach cancer, prostate cancer, breast cancer, kidney cancer, liver cancer, encephaloma, lung cancer, uterine cancer, colon cancer, bladder cancer, pancreatic cancer, and blood cancer.  
     
     
         3 . A method for the prophylaxis or treatment of cancer, comprising the administration of an anticancer composition comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof.  
       
         
           
           
               
               
           
         
       
     
     
         4 . A method for inhibiting the metastasis of cancer, comprising the administration of an anticancer composition comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof.

Join the waitlist — get patent alerts

Track US2007037889A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.